Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Eagle's Eye View: Your Weekly CV Update From ACC.org

Eagle's Eye View: When DOACS Should Not Be Used as Standard Treatment, Intervention for Complex Coronary Lesions through OCT vs IVUS, Impact of Bempedoic Acid on CV Events

24 Jan 2024

Description

In this week's View, Dr. Eagle discusses a JACC State of the Art Review noting direct oral anticoagulants (DOACs) should not be standard treatment. He then explores various ways of guiding intervention for complex coronary lesions by optical coherence tomography (OCT) or intravascular ultrasound (IVUS). Finally, Dr. Eagle talks about a prespecified analysis of the CLEAR Outcomes Randomized Trial on the impact of bempedoic acid on total cardiovascular events.  Subscribe to Eagle's Eye View  

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.